Western blot analysis of the lung tissues found that the levels of pulmonary fibrosis markers including α-SMA, p-Smad3 and Fn1 were higher in RTN3-null group than in Wild type group after bleomycin treatment (Fig. 2E). The gene discussed is ACTA1; the disease is pulmonary fibrosis.